Beckman Coulter Diagnostics has won FDA clearance for its automated Access AMH immunoassay for in vitro diagnostic (IVD) use in the U.S. The Access AMH assay is a paramagnetic particle chemiluminescent immunoassay that is designed for quantitative determination of anti-Müllerian hormone (AMH) levels. Access AMH is designed to aid healthcare…

In the first reported first use of CRISPR/Cas9 genome editing to study gene function in developing human preimplantation embryos, researchers from the U.K. and South Korea have applied the technology to target the POU5F1 gene, which encodes the pluripotency transcription factor OCT4 during embryogenesis. “If we knew the key genes…

Genetically speaking, all humans are 99.9% identical, but that tiny 0.1% variation has signfiicant consequences, influencing everything from the color of your hair or the size of your hads, to your risk of developing a disease. Although variants are scattered throughout the genome, scientists have largely ignored the stretches of…

 New computational genomics company Phosphorous announced earlier this week it secured $10 million in a Series A funding round led by FirstMark Capital, its founders, and undisclosed angel investors. The company’s focus is to build a worldwide genomic data network that will help healthcare providers, researchers, and patients leverage genomic…

Imagine yourself suspended a couple of hundred feet below the surface of the ocean. The sheer weight of the immense column of water pushing down on your chest makes each breath a harrowing task. Now picture that your only recourse to collect vital oxygen is to breathe laboriously throw a…